{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,15]],"date-time":"2025-04-15T17:05:21Z","timestamp":1744736721853,"version":"3.37.3"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"S2","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,9,13]],"date-time":"2021-09-13T00:00:00Z","timestamp":1631491200000},"content-version":"vor","delay-in-days":12,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"EU Third Health Programme","award":["761319"],"award-info":[{"award-number":["761319"]}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["PD\/BD\/128008\/2016"],"award-info":[{"award-number":["PD\/BD\/128008\/2016"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004334","name":"Merck","doi-asserted-by":"publisher","award":["EuroTEST-2019"],"award-info":[{"award-number":["EuroTEST-2019"]}],"id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008897","name":"Janssen Pharmaceuticals","doi-asserted-by":"publisher","award":["EuroTEST-2019"],"award-info":[{"award-number":["EuroTEST-2019"]}],"id":[{"id":"10.13039\/100008897","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2021,9]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Country level policies and practices of testing and care for HIV, viral hepatitis and sexually transmitted infections are lagging behind European recommendations on integration across diseases. Building on previous experiences and evidence, the INTEGRATE Joint Action arranged four national stakeholder meetings. The aim was to foster cross-disciplinary and cross-disease collaborations at national level as a vehicle for strengthened integration of testing and care services. This article presents the methodology and discusses main outcomes and recommendations of these meetings.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Local partners in Croatia, Italy, Lithuania and Poland oversaw the planning, agenda development and identification of key persons to invite to ensure that meetings addressed main challenges and issues of the respective countries. Invited national stakeholders represented policy and public health institutions, clinical settings, testing sites and community organisations. National experts and experts from other European countries were invited as speakers and facilitators. Main topic discussed was how to increase integration across HIV, viral hepatitis and sexually transmitted infections in testing and care policies and practice; tuberculosis was also addressed in Lithuania and Italy.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The agendas reflected national contexts and the meetings provided a forum to engage stakeholders knowledgeable of the national prevention, testing and care systems in interaction with international experts who shared experiences of the steps needed to achieve integration in policies and practice. The evaluations showed that participants found meetings relevant, important and beneficial for furthering integration. Of the respondents 78% agreed or strongly agreed that there was a good representation of relevant national stakeholders, and 78% that decision\/action points were made on how to move the agenda forward. The importance of securing participation from high level national policy makers was highlighted. Outcomes were nationally tailored recommendations on integrated policies and strategies, diversification of testing strategies, stigma and discrimination, key populations, cost effectiveness, surveillance and funding.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Shifting from single to multi-disease approaches require collaboration among a broad range of actors and national multi-stakeholder meetings have proven excellent to kick-start this. Face-to-face meetings of key stakeholders represent a unique opportunity to share cross-sectoral perspectives and experiences, identify gaps in national policies and practices and agree on required next steps.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12879-021-06492-y","type":"journal-article","created":{"date-parts":[[2021,9,13]],"date-time":"2021-09-13T15:03:30Z","timestamp":1631545410000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["National multi-stakeholder meetings: a tool to support development of integrated policies and practices for testing and prevention of HIV, viral hepatitis, TB and STIs"],"prefix":"10.1186","volume":"21","author":[{"given":"Daniel","family":"Sim\u00f5es","sequence":"first","affiliation":[]},{"given":"Raimonda","family":"Matulionyt\u00e9","sequence":"additional","affiliation":[]},{"given":"Loreta","family":"Stoniene","sequence":"additional","affiliation":[]},{"given":"Piotr","family":"Wysocki","sequence":"additional","affiliation":[]},{"given":"Justyna","family":"Kowalska","sequence":"additional","affiliation":[]},{"given":"Nadia","family":"Gasbarrini","sequence":"additional","affiliation":[]},{"given":"Lella","family":"Cosmaro","sequence":"additional","affiliation":[]},{"given":"Tatjana Nemeth","family":"Bla\u017ei\u0107","sequence":"additional","affiliation":[]},{"given":"Arian","family":"Di\u0161kovi\u0107","sequence":"additional","affiliation":[]},{"given":"Zoran","family":"Dominkovi\u0107","sequence":"additional","affiliation":[]},{"given":"Iva","family":"Jovovic","sequence":"additional","affiliation":[]},{"given":"Ilona","family":"Razmiene","sequence":"additional","affiliation":[]},{"given":"Manuel","family":"Maffeo","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2586-0248","authenticated-orcid":false,"given":"Stine F.","family":"Jakobsen","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2021,9,13]]},"reference":[{"key":"6492_CR1","unstructured":"European Centre for Disease Prevention and Control. Public health guidance on HIV, hepatitis B and C testing in the EU\/EEA \u2013 An integrated approach. Stockholm: ECDC; 2018. https:\/\/www.ecdc.europa.eu\/en\/publications-data\/public-health-guidance-hiv-hepatitis-b-and-c-testing-eueea. Accessed 31 May 2021."},{"key":"6492_CR2","unstructured":"World Health Organization: Compendium of good practices in the health sector response to HIV in the WHO European Region. 2018. WHO Reginal Office for Europe, Copenhagen. https:\/\/www.euro.who.int\/__data\/assets\/pdf_file\/0004\/375997\/HIV-Comp-Aug-29-2.pdf . Accessed 31 May 2021."},{"issue":"8","key":"6492_CR3","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1097\/OLQ.0000000000000002","volume":"40","author":"RJ Steiner","year":"2013","unstructured":"Steiner RJ, Aquino G, Fenton KA. Enhancing HIV\/AIDS, viral hepatitis, sexually transmitted disease, and tuberculosis prevention in the United States through program collaboration and service integration: the case for broader implementation. Sex Transm Dis. 2013;40(8):663\u20138. https:\/\/doi.org\/10.1097\/OLQ.0000000000000002.","journal-title":"Sex Transm Dis"},{"key":"6492_CR4","doi-asserted-by":"publisher","first-page":"i4","DOI":"10.1093\/heapol\/czq060","volume":"25","author":"A Shigayeva","year":"2010","unstructured":"Shigayeva A, Atun R, McKee M, Coker R. Health systems, communicable diseases and integration. Health Policy Plan. 2010;25:i4\u201320. https:\/\/doi.org\/10.1093\/heapol\/czq060.","journal-title":"Health Policy Plan"},{"key":"6492_CR5","unstructured":"Joint Action on integrating prevention, testing and linkage to care strategies across HIV, viral hepatitis, TB and STIs in Europe (INTEGRATE) co-funded by the EU Commission under the Third Health Programme 2017\u20132021. www.integrateja.eu . Accessed 31 May 2021."},{"key":"6492_CR6","unstructured":"Optimising testing and linkage to care for HIV across Europe (OptTEST by HiE) project co-funded by the EU Commission under the Second Health Programme 2014\u20132017. www.opttest.eu. Accessed 31 May 2021."},{"key":"6492_CR7","unstructured":"S Chanos. Linkage to and retention in care: Experiences from Greece and challenges for the future OptTEST Meeting Report National Stakeholder Meeting Athens, Greece, Monday, 26th September 2016. https:\/\/www.opttest.eu\/Publications\/Other-Publications . Accessed 31 May 2021."},{"key":"6492_CR8","unstructured":"J del Amo and M Manzanera for OpTEST by HiE. Meeting Report: National Stakeholder Meeting. Optimizing HIV testing and linkage to care in Spain. 2017. Spain, September 2017. https:\/\/www.opttest.eu\/Publications\/Other-Publications. Accessed 31 May 2021."},{"key":"6492_CR9","unstructured":"A Sullivan, C Rae, I Sperle, J Casabona, M Dutarte and R Lugo - for OptTEST by HIV in Europe. Meeting report: Improving the early diagnosis of HIV and linkage to care in Catalonia and Europe Barcelona, Spain, 10 July 2017. https:\/\/www.opttest.eu\/Publications\/Other-Publications. Accessed 31 May 2021."},{"key":"6492_CR10","unstructured":"D Sim\u00f5es and R Freitas for OptTEST by HIV in Europe. Meeting Report: National Stakeholder Meeting on Implementation of HIV test in Primary Care & Linkage to Care in Portugal. Portugal, 2017. Portugal, September 2017. https:\/\/www.opttest.eu\/Publications\/Other-Publications. Accessed 31 May 2021."},{"key":"6492_CR11","doi-asserted-by":"crossref","unstructured":"Kowalska J, Grzeszczuk A, Pyziak-Kowalska K et al. Shaping the HIV epidemic in Poland \u2013 proceedings from the first Polish workshop on cascade of care in HIV. HIV AIDS Rev 2017; 16. https:\/\/www.opttest.eu\/Publications\/Scientific-Publications. Accessed 31 May 2021.","DOI":"10.5114\/hivar.2017.68804"},{"key":"6492_CR12","unstructured":"EuroTEST is an initiative that provides a European platform for information exchange and activities to improve early diagnosis and care of HIV, viral hepatitis, sexually transmitted infections and tuberculosis. www.eurotest.org. Accessed 31 may 2021."},{"key":"6492_CR13","unstructured":"European Testing Week is a European testing campaign. http:\/\/www.testingweek.eu. Accessed 31 May 2021."},{"key":"6492_CR14","unstructured":"Integrate partners responsible for the National Stakeholder Meetings: In Lithuania: Department of Infectious Diseases and Dermatovenerology, Faculty of Medicine, Vilnius University; Vilnius University Hospital Santaros Klinikos, the Republican Centre for Addictive Disorders, National Public Health Surveillance Laboratory, Centre for Communicable Diseases and AIDS. In Poland: National AIDS Centre Agency of the Ministry of Health, Medical University of Warsaw. In Italy: Fondazione Villa Maraini Onlus, Fondazione LILA Milano \u2013 Italian League for Fighting AIDS, Arcigay Associazione LGBTI Italiana, Croce Rossa Italiana, Italy. In Croatia: Croatian Institute of Public Health, Croatian association for HIV and viral hepatitis, Iskorak, Life Quality Improvement Association (Flight)"},{"key":"6492_CR15","unstructured":"The Dublin Declaration on Partnership to Fight HIV\/AIDS in Europe and Central Asia. Link: https:\/\/www.ecdc.europa.eu\/en\/all-topics-zhiv-infection-and-aidsprevention-and-control\/monitoring-implementation-dublin. Accessed 31 May 2021."},{"key":"6492_CR16","unstructured":"The ESTICOM project has developed a training programme for Community Health Workers (CHWs) working with gay, bisexual, and other men who have sex with men (MSM). Link: https:\/\/www.esticom.eu\/Webs\/ESTICOM\/EN\/training-programme\/training-programme-node.html. Accessed 31 May 2021."}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-021-06492-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-021-06492-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-021-06492-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,13]],"date-time":"2021-09-13T15:05:45Z","timestamp":1631545545000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-021-06492-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":16,"journal-issue":{"issue":"S2","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["6492"],"URL":"https:\/\/doi.org\/10.1186\/s12879-021-06492-y","relation":{},"ISSN":["1471-2334"],"issn-type":[{"type":"electronic","value":"1471-2334"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"29 July 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 September 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Authors declare that they have no competing interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"795"}}